Cargando…

LINC01089 blocks malignant progression of thyroid cancer by binding miR-27b-3p to enhance the FBLN5 protein level

LINC01089 suppresses the malignant progression of breast, colorectal, and non-small cell lung cancers. However, the function of LINC01089 in thyroid cancer has not yet been elucidated. Here, The Cancer Genome Atlas (TCGA) database showed that LINC01089 expression is remarkably reduced in thyroid can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yong-qin, Huang, Kun-song, Chong, Tsz-Hong, Li, Jin-yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616979/ https://www.ncbi.nlm.nih.gov/pubmed/36306007 http://dx.doi.org/10.1007/s12672-022-00580-4

Ejemplares similares

LINC01089 Blocks the Proliferation and Metastasis of Colorectal Cancer Cells via Regulating miR-27b-3p/HOXA10 Axis
por: Li, Ming, et al.
Publicado: (2020)

LINC01089 is a tumor-suppressive lncRNA in gastric cancer and it regulates miR-27a-3p/TET1 axis
por: Guo, Xufeng, et al.
Publicado: (2020)

LINC01089 Inhibits Tumorigenesis and Epithelial–Mesenchymal Transition of Non-small Cell Lung Cancer via the miR-27a/SFRP1/Wnt/β-catenin Axis
por: Li, Xingkai, et al.
Publicado: (2020)

LINC01089 suppresses lung adenocarcinoma cell proliferation and migration via miR-301b-3p/STARD13 axis
por: Qian, Ye, et al.
Publicado: (2021)

Long Non-Coding RNA LINC01089 Enhances the Development of Gastric Cancer by Sponging miR-145-5p to Mediate SOX9 Expression
por: Wang, Fengyong, et al.
Publicado: (2020)

LINC01089 functions as a ceRNA for miR-152-3p to inhibit non‐small lung cancer progression through regulating PTEN
por: Zhang, Huixian, et al.
Publicado: (2021)

Retraction Note: LINC01089 functions as a ceRNA for miR-152-3p to inhibit non‐small lung cancer progression through regulating PTEN
por: Zhang, Huixian, et al.
Publicado: (2022)

LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells: LIMT contributes to sorafenib chemoresistance in HCC
por: Sun, Jing, et al.
Publicado: (2021)

Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer
por: Yuan, Hongfan, et al.
Publicado: (2019)

miR-370-3p as a Novel Biomarker Promotes Breast Cancer Progression by Targeting FBLN5
por: Mao, Jiahui, et al.
Publicado: (2021)

Clinical and Biological Significances of FBLN5 in Gastric Cancer
por: Bian, Xiulan, et al.
Publicado: (2023)

miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5
por: Chuang, Tsai-Der, et al.
Publicado: (2012)

Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2020)

FBLN5 is targeted by microRNA-27a-3p and suppresses tumorigenesis and progression in high-grade serous ovarian carcinoma
por: Li, Rongrong, et al.
Publicado: (2020)

Adult-onset demyelinating neuropathy associated with FBLN5 gene mutation
por: Cheng, Si, et al.
Publicado: (2017)

Long Intergenic Non-Protein Coding RNA 01089 Weakens Tumor Proliferation, Migration, and Invasion by Sponging miR-3187-3p in Non-Small Cell Lung Cancer
por: Zhang, Dongdong, et al.
Publicado: (2020)

Contribution of FBLN5 to Unstable Plaques in Carotid Atherosclerosis via mir128 and mir532–3p Based on Bioinformatics Prediction and Validation
por: Zheng, Lin, et al.
Publicado: (2022)

LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression
por: Jia, Meng, et al.
Publicado: (2020)

New insight into clinical heterogeneity and inheritance diversity of FBLN5-related cutis laxa
por: Gharesouran, Jalal, et al.
Publicado: (2021)

LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p
por: Han, Xiancheng, et al.
Publicado: (2021)

LINC01311 exerts an inhibitory effect in thyroid cancer progression by targeting the miR-146b-5p/IMPA2 axis
por: Liu, Mengjiang, et al.
Publicado: (2022)

Knockdown of LINC02471 Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375
por: Chen, Dongfang, et al.
Publicado: (2020)

LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis
por: Li, Guangjun, et al.
Publicado: (2019)

MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer
por: Xu, Hui, et al.
Publicado: (2020)

LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p/MAPK1 axis
por: Wang, Kang, et al.
Publicado: (2022)

Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease
por: Yousefi, Maryam, et al.
Publicado: (2022)

FBLN4 as candidate gene associated with long-term and short-term survival with primary glioblastoma
por: Li, Fubin, et al.
Publicado: (2017)

Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer
por: Hao, Yi, et al.
Publicado: (2021)

Genetic screening for anticancer genes highlights FBLN5 as a synthetic lethal partner of MYC
por: Masood, Motasim, et al.
Publicado: (2023)

Genetic variants and haplotypes in fibulin-5 (FBLN5) are associated with pseudoexfoliation glaucoma but not with pseudoexfoliation syndrome
por: Kapuganti, Ramani Shyam, et al.
Publicado: (2023)

LINC00511 enhances LUAD malignancy by upregulating GCNT3 via miR-195-5p
por: Zhang, Youyi, et al.
Publicado: (2022)

LINC-DUBR Suppresses Malignant Progression of Ovarian Cancer by Downregulating miR-107 to Induce SMAC Expression
por: Han, Zhehui, et al.
Publicado: (2022)

LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction]
Publicado: (2023)

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells
por: Salah, Zaidoun, et al.
Publicado: (2015)

LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis
por: Pan, Xin, et al.
Publicado: (2018)

miR-27b Targets HOXB8 to Inhibit Malignant Behaviors of Osteosarcoma
por: Wu, Yingyong, et al.
Publicado: (2019)

LINC00470 promotes tumour proliferation and invasion, and attenuates chemosensitivity through the LINC00470/miR‐134/Myc/ABCC1 axis in glioma
por: Wu, Changwu, et al.
Publicado: (2020)

miR-27a-3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells
por: Chen, Hongxin, et al.
Publicado: (2021)

miR-27a-3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells
por: Chen, Hongxin, et al.
Publicado: (2021)

Therapeutic manipulation of angiogenesis with miR-27b
por: Veliceasa, Dorina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hpk4ljf9ra7oi1an353923h3v3